Form 4: Amgen Executive Murdo Gordon Reports Changes in Beneficial Ownership
SEC Form 4 Filing
EVP Murdo Gordon reports disposition of Amgen shares to cover tax obligations related to vested restricted stock units.
Summary
- On May 2, 2025, Murdo Gordon, EVP, Global Commercial Operations at Amgen Inc., reported the disposition of 780 and 740 shares of common stock to cover tax obligations.
- The transactions were executed at a price of $283.78 per share.
- Following the reported transactions, Gordon directly owns 46,066 shares of Amgen common stock, which includes 442 Dividend Equivalents (DEs).
Sentiment
Score: 5
Explanation: This is a routine filing related to stock transactions for tax purposes, and does not indicate any significant positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock. This filing indicates routine tax-related stock sales.
Key Dates
| Date | Description |
|---|---|
| 05/02/2025 | Date of stock disposition. |
| 05/06/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, Amgen, Murdo Gordon, Stock Disposition, Tax Obligations, Dividend Equivalents, AMGN
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.